Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide researched for its potent role in glucose regulation, insulin sensitivity, and body weight control. It is commonly studied in models involving type 2 diabetes, obesity, and metabolic disorders, offering insight into incretin-based therapies.
CURRENT BATCH: TZ-30-251021
Reviews
There are no reviews yet.